Abstract
In hospitalized patients with SARS-CoV-2 infection, outcomes markedly differ between locations, regions and countries. One possible cause for these variations in outcomes could be differences in patient treatment limitations (PTL) in different locations. We thus studied their role as predictor for mortality in a population of hospitalized patients with COVID-19. In a region with high incidence of SARS-CoV-2 infection, adult hospitalized patients with PCR-confirmed SARS-CoV-2 infection were prospectively registered and characterized regarding sex, age, vital signs, symptoms, comorbidities (including Charlson comorbidity index (CCI)), transcutaneous pulse oximetry (SpO2) and laboratory values upon admission, as well as ICU-stay including respiratory support, discharge, transfer to another hospital and death. PTL assessed by routine clinical procedures comprised the acceptance of ICU-therapy, orotracheal intubation and/or cardiopulmonary resuscitation. Among 526 patients included (median [quartiles] age 73 [57; 82] years, 47% female), 226 (43%) had at least one treatment limitation. Each limitation was associated with age, dementia and eGFR (p < 0.05 each), that regarding resuscitation additionally with Charlson comorbidity index ...Continue Reading
References
Jan 1, 1987·Journal of Chronic Diseases·M E CharlsonC R MacKenzie
May 6, 2009·Annals of Internal Medicine·Andrew S LeveyUNKNOWN CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)
Jun 24, 2018·Resuscitation·Sara StreamCatherine Constable
Jan 25, 2020·The New England Journal of Medicine·Na ZhuUNKNOWN China Novel Coronavirus Investigating and Research Team
Apr 7, 2020·JAMA : the Journal of the American Medical Association·Giacomo GrasselliUNKNOWN COVID-19 Lombardy ICU Network
Apr 10, 2020·The European Respiratory Journal·Rong-Hui DuHuan-Zhong Shi
Apr 16, 2020·Respiratory Research·Lei GaoDong-Ying Zhang
Apr 19, 2020·Chest·Ruchong ChenUNKNOWN Medical Treatment Expert Group for COVID-19
May 15, 2020·Science·Henrik SaljeSimon Cauchemez
May 23, 2020·Lancet·Matthew J CummingsMax R O'Donnell
May 24, 2020·BMJ : British Medical Journal·Annemarie B DochertyUNKNOWN ISARIC4C investigators
Jul 4, 2020·The Lancet. Public Health·Jonathan HewittUNKNOWN COPE Study Collaborators
Jul 6, 2020·Respiratory Research·Wenjing YeLing Yang
Jul 6, 2020·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·B ChengA Deng
Jul 8, 2020·Critical Care : the Official Journal of the Critical Care Forum·Jiqian XuYou Shang
Jul 9, 2020·Nature·Elizabeth J WilliamsonBen Goldacre
Jul 16, 2020·Journal of Intensive Care·Yumeng YaoBijie Hu
Jul 28, 2020·International Journal of Environmental Research and Public Health·Beatriz Poblador-Plou EpiChron Group
Aug 1, 2020·The Lancet. Respiratory Medicine·Christian KaragiannidisReinhard Busse
Aug 11, 2020·The Lancet. Respiratory Medicine·Elisabet PujadasCarlos Cordon-Cardo
Aug 12, 2020·JAMA Internal Medicine·Seungjae LeeTae Hyong Kim
Aug 22, 2020·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Irit NachtigallJulius Dengler
Aug 25, 2020·EClinicalMedicine·Pedro David Wendel GarciaUNKNOWN RISC-19-ICU Investigators
Sep 24, 2020·JAMA Network Open·George N IoannouVincent S Fan
Sep 25, 2020·American Journal of Physiology. Renal Physiology·Vincenzo CantaluppiClaudio Ronco